Literature DB >> 10792369

Effective vaccination against tuberculosis-a new ray of hope.

J M Grange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10792369      PMCID： PMC1905635          DOI： 10.1046/j.1365-2249.2000.01145.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  22 in total

1.  The Koch phenomenon and delayed hypersensitivity: 1891-1991.

Authors:  G H Bothamley; J M Grange
Journal:  Tubercle       Date:  1991-03

2.  Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172).

Authors:  D Dlugovitzky; O Bottasso; J C Dominino; E Valentini; R Hartopp; M Singh; C Stanford; J Stanford
Journal:  Respir Med       Date:  1999-08       Impact factor: 3.415

3.  A comparison of the responsiveness to four new tuberculins among Indonesian patients with pulmonary tuberculosis and healthy subjects.

Authors:  T Kardjito; J S Beck; J M Grange; J L Stanford
Journal:  Eur J Respir Dis       Date:  1986-09

4.  A preliminary investigation of the responsiveness or otherwise of patients and staff of a leprosy hospital to groups of shared or species antigens of mycobacteria.

Authors:  J L Stanford; P M Nye; G A Rook; N Samuel; A Fairbank
Journal:  Lepr Rev       Date:  1981-12       Impact factor: 0.537

5.  How environmental mycobacteria may predetermine the protective efficacy of BCG.

Authors:  J L Stanford; M J Shield; G A Rook
Journal:  Tubercle       Date:  1981-03

6.  Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem.

Authors:  K Styblo; J Meijer
Journal:  Tubercle       Date:  1976-03

7.  Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination.

Authors:  A Marchant; T Goetghebuer; M O Ota; I Wolfe; S J Ceesay; D De Groote; T Corrah; S Bennett; J Wheeler; K Huygen; P Aaby; K P McAdam; M J Newport
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

8.  The 19-kD antigen and protective immunity in a murine model of tuberculosis.

Authors:  V V Yeremeev; I V Lyadova; B V Nikonenko; A S Apt; C Abou-Zeid; J Inwald; D B Young
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

9.  Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens.

Authors:  H M Surcel; M Troye-Blomberg; S Paulie; G Andersson; C Moreno; G Pasvol; J Ivanyi
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

10.  Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.

Authors:  J M Pönnighaus; P E Fine; J A Sterne; R J Wilson; E Msosa; P J Gruer; P A Jenkins; S B Lucas; N G Liomba; L Bliss
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321
View more
  4 in total

1.  Bacterial evolution: Emergence of virulence in TB.

Authors:  Patrick J Brennan
Journal:  Nat Microbiol       Date:  2016-01-27       Impact factor: 17.745

2.  Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro.

Authors:  F A Post; C Manca; O Neyrolles; B Ryffel; D B Young; G Kaplan
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma.

Authors:  Ferdinando C M Cananzi; Satvinder Mudan; Mary Dunne; Nneka Belonwu; Angus G Dalgleish
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

4.  Glutamate mediated metabolic neutralization mitigates propionate toxicity in intracellular Mycobacterium tuberculosis.

Authors:  Jae Jin Lee; Juhyeon Lim; Shengjia Gao; Christopher P Lawson; Mark Odell; Saki Raheem; JeongIm Woo; Sung-Ho Kang; Shin-Seok Kang; Bo-Young Jeon; Hyungjin Eoh
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.